Endoluxe Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A3

  • Latest Deal Amount
  • $1M

  • Investors
  • 5

Endoluxe General Information

Description

Developer of healthcare vision system designed to create a mobile, integrated, and affordable platform for endoscopic procedures. The company's system can be used with a variety of endoscopes maintaining the precision alignment needed for optimal visualization required in the surgery, enabling surgeons to perform endoscopic procedures with an integrated suite of software features connected within the cloud.

Contact Information

Website
www.endoluxe.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5337 Happy Hollow Road
  • Dunwoody, GA 30360
  • United States
+1 (919)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech
Corporate Office
  • 5337 Happy Hollow Road
  • Dunwoody, GA 30360
  • United States
+1 (919)

Endoluxe Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endoluxe Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A3) 10-Nov-2023 $1M Completed Generating Revenue
4. Angel (individual) 21-Jun-2022 Completed Generating Revenue
3. Accelerator/Incubator 07-Jun-2022 Completed Generating Revenue
2. Later Stage VC (Series A2) 17-Jun-2021 $2.55M $6.05M Completed Generating Revenue
1. Early Stage VC (Series A1) 29-Mar-2017 $3.5M $3.5M Completed Generating Revenue
To view Endoluxe’s complete valuation and funding history, request access »

Endoluxe Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A3
Series A2
Series A1 4,200,266 $0.000100 4% $0.14 $0.14 1x $0.14 11.36%
To view Endoluxe’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Endoluxe Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of healthcare vision system designed to create a mobile, integrated, and affordable platform for endoscopic pr
Diagnostic Equipment
Dunwoody, GA
9 As of 2025

Tuttlingen, Germany
 

Herefordshire, United Kingdom
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Endoluxe Competitors (2)

One of Endoluxe’s 2 competitors is KARL STORZ, a Corporation company based in Tuttlingen, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
KARL STORZ Corporation Tuttlingen, Germany
Prometheus Medical Formerly PE-Backed Herefordshire, United Kingdom
You’re viewing 2 of 2 competitors. Get the full list »

Endoluxe Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Endoluxe Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240341572-A1 Technologies for endoscopy, laparoscopy, and other scopic procedures and methods of manufacture and use thereof Pending 13-Mar-2023
US-20230218146-A1 Systems, apparatuses, and methods for endoscopy Pending 10-Jan-2022
US-20230248211-A1 Systems, apparatuses, and methods for endoscopy Active 10-Jan-2022
US-11864730-B2 Systems, apparatuses, and methods for endoscopy Active 10-Jan-2022
US-20240197148-A1 Systems, apparatuses, and methods for endoscopy Pending 10-Jan-2022 A61B1/0005
To view Endoluxe’s complete patent history, request access »

Endoluxe Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endoluxe Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mammoth Investors Venture Capital Minority
MedTech Innovator Accelerator/Incubator Minority
Ashish Vengsarkar Angel (individual) Minority
Nayana Patel Angel (individual) Minority
Sriram Ramanathan Angel (individual) Minority
To view Endoluxe’s complete investors history, request access »

Ready to get started?

Request a free trial

Endoluxe FAQs

  • When was Endoluxe founded?

    Endoluxe was founded in 2013.

  • Where is Endoluxe headquartered?

    Endoluxe is headquartered in Dunwoody, GA.

  • What is the size of Endoluxe?

    Endoluxe has 9 total employees.

  • What industry is Endoluxe in?

    Endoluxe’s primary industry is Diagnostic Equipment.

  • Is Endoluxe a private or public company?

    Endoluxe is a Private company.

  • What is the current valuation of Endoluxe?

    The current valuation of Endoluxe is .

  • What is Endoluxe’s current revenue?

    The current revenue for Endoluxe is .

  • How much funding has Endoluxe raised over time?

    Endoluxe has raised $9.6M.

  • Who are Endoluxe’s investors?

    Mammoth Investors, MedTech Innovator, Ashish Vengsarkar, Nayana Patel, and Sriram Ramanathan have invested in Endoluxe.

  • Who are Endoluxe’s competitors?

    KARL STORZ and Prometheus Medical are competitors of Endoluxe.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »